The bill calls for the repeal of a nearly $30 billion excise tax on medical devices that would take effect in 2013.
The statement was attributed to Stephen J. Ubl, president and CEO of AdvaMed. His comments included the following, according to the release:
“On behalf of the nearly 2 million men and women whose jobs are supported by the medical technology industry, we would like to thank Rep. Erik Paulsen (R-Minn.), the author of the bill that passed today, for his tireless leadership in seeking repeal of this onerous tax, as well as all the other members of the House who supported the legislation.
“AdvaMed encourages the U.S. Senate to join the House and act promptly to repeal this counterproductive, job-destroying tax.”
Related Articles on AdvaMed:
AdvaMed Praises House and Senate for Passage of Medical Device User Fee Reauthorization
AdvaMed Encourages House to Reauthorize Medical Device User Fee Act
AdvaMed Commends Congress on Progress on Reauthorization of Medical Device User Fees
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
